Preclinical evaluation of mps1 inhibition in uterine leiomyosarcoma.

被引：0
|
作者：
Wong, Ho Shing [1 ]
Lee, Hok Yeung H. [1 ]
Tse, Ka Yu [1 ]
Mak, Tak Wah [2 ]
Ip, Philip P. C. [1 ]
机构：
[1] Univ Hong Kong, Hong Kong, Peoples R China
[2] Campbell Family Inst Breast Canc Res, Toronto, ON, Canada
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
980
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Preoperative evaluation in women with uterine leiomyosarcoma. A nationwide cohort study
    Skorstad, Mette
    Kent, Andrew
    Lieng, Marit
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2016, 95 (11) : 1228 - 1234
  • [2] Neuropilin 1 in uterine leiomyosarcoma. Clinical and pathological analysis
    Bobinski, Marcin
    Okla, Karolina
    Kotarski, Jan
    Szumilo, Justyna
    Polak, Grzegorz
    Sobstyl, Malgorzata
    Bednarek, Wieslawa
    GINEKOLOGIA POLSKA, 2018, 89 (01) : 7 - 12
  • [3] MPS1 inhibition in breast cancer
    Linardopoulos, Spiros
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S80 - S80
  • [4] Small bowel metastasis of a uterine leiomyosarcoma.
    Sidani, H
    Ezzedine, J
    Zbibo, R
    Jalloul, R
    Ramadan, M
    JOURNAL DE CHIRURGIE, 1996, 133 (07): : 346 - 347
  • [5] Identifying actionable mutations in uterine leiomyosarcoma.
    Soumerai, Tara
    Hyman, David Michael
    Murali, Rajmohan
    Zehir, Ahmet
    O'Cearbhaill, Roisin Eilish
    Arcila, Maria E.
    Aghajanian, Carol
    Soslow, Robert A.
    Solit, David B.
    Hensley, Martee Leigh
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Characterization of novel MPS1 inhibitors with preclinical anticancer activity
    M Jemaà
    L Galluzzi
    O Kepp
    L Senovilla
    M Brands
    U Boemer
    M Koppitz
    P Lienau
    S Prechtl
    V Schulze
    G Siemeister
    A M Wengner
    D Mumberg
    K Ziegelbauer
    A Abrieu
    M Castedo
    I Vitale
    G Kroemer
    Cell Death & Differentiation, 2013, 20 : 1532 - 1545
  • [7] Characterization of novel MPS1 inhibitors with preclinical anticancer activity
    Jemaa, M.
    Galluzzi, L.
    Kepp, O.
    Senovilla, L.
    Brands, M.
    Boemer, U.
    Koppitz, M.
    Lienau, P.
    Prechtl, S.
    Schulze, V.
    Siemeister, G.
    Wengner, A. M.
    Mumberg, D.
    Ziegelbauer, K.
    Abrieu, A.
    Castedo, M.
    Vitale, I.
    Kroemer, G.
    CELL DEATH AND DIFFERENTIATION, 2013, 20 (11): : 1532 - 1545
  • [8] Secondary cytoreductive surgery in recurrent uterine leiomyosarcoma.
    Nicolo, Bizzarri
    Valentina, Ghirardi
    Giacomo, Di Fiore
    Giovanni, Scambia
    Anna, Fagotti
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 260 - 260
  • [9] SAC abrogation by MPS1 kinase inhibition: preclinical proof of concept of a novel approach to tumor treatment
    Mumberg, Dominik
    Siemeister, Gerhard
    Wengner, Antje M.
    Koppitz, Marcus
    Schulze, Volker
    Bader, Benjamin
    Prechtl, Stefan
    Kreft, Bertolt
    Ziegelbauer, Karl
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Chemical Genetic Inhibition of Mps1 in Stable Human Cell Lines Reveals Novel Aspects of Mps1 Function in Mitosis
    Sliedrecht, Tale
    Zhang, Chao
    Shokat, Kevan M.
    Kops, Geert J. P. L.
    PLOS ONE, 2010, 5 (04):
12345